ALPS Medical Breakthroughs ETF (NYSEARCA:SBIO – Get Free Report)’s stock price dropped 1.7% during mid-day trading on Monday . The company traded as low as $37.91 and last traded at $37.92. Approximately 29,943 shares traded hands during mid-day trading, an increase of 179% from the average daily volume of 10,717 shares. The stock had previously closed at $38.56.
ALPS Medical Breakthroughs ETF Stock Performance
The firm has a 50-day moving average of $38.63 and a 200 day moving average of $36.68.
Institutional Inflows and Outflows
A number of institutional investors have recently modified their holdings of the stock. Griffin Asset Management Inc. raised its stake in shares of ALPS Medical Breakthroughs ETF by 188.3% in the second quarter. Griffin Asset Management Inc. now owns 22,965 shares of the company’s stock worth $771,000 after purchasing an additional 15,000 shares during the last quarter. Financial Advocates Investment Management raised its holdings in ALPS Medical Breakthroughs ETF by 5.3% during the 2nd quarter. Financial Advocates Investment Management now owns 7,670 shares of the company’s stock valued at $258,000 after acquiring an additional 385 shares during the period. Ridgewood Investments LLC purchased a new position in ALPS Medical Breakthroughs ETF during the 2nd quarter valued at about $675,000. International Assets Investment Management LLC bought a new stake in ALPS Medical Breakthroughs ETF during the 3rd quarter worth approximately $61,430,000. Finally, Jane Street Group LLC purchased a new stake in shares of ALPS Medical Breakthroughs ETF in the third quarter worth $366,000.
ALPS Medical Breakthroughs ETF Company Profile
The ALPS Medical Breakthroughs ETF (SBIO) is an exchange-traded fund that is based on the S-Network Medical Breakthroughs index. The fund tracks, a market-cap weighted index comprising US-listed biotech companies with one or more drugs currently in either Phase II or Phase III FDA clinical trials. SBIO was launched on Dec 31, 2014 and is managed by ALPS.
Featured Articles
- Five stocks we like better than ALPS Medical Breakthroughs ETF
- How to Use High Beta Stocks to Maximize Your Investing Profits
- The Great CPU Race: AMD and Intel Battle for Dominance
- Business Services Stocks Investing
- GameStop Turns a Profit: So What? It’s Still Not Worth Investing
- What Investors Must Know About Over-the-Counter (OTC) Stocks
- C3.ai Stock Surges on Strong Sales Despite Profit Concerns
Receive News & Ratings for ALPS Medical Breakthroughs ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ALPS Medical Breakthroughs ETF and related companies with MarketBeat.com's FREE daily email newsletter.